Education
About Us
Working with TipRanks
Follow Us
Modus Therapeutics Holding AB (DE:99Z)
FRANKFURT:99Z
99Z Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.07 - €0.19
Previous CloseN/A
Volume0.00
Average Volume (3M)333.00
Market Cap
€4.32M
Enterprise Value€60.49M
Total Cash (Recent Filing)-kr1.38M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta-0.61
Next Earnings
May 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding35,938,900
10 Day Avg. Volume1,000
30 Day Avg. Volume333
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
99Z FAQ
What was Modus Therapeutics Holding AB’s price range in the past 12 months?
Modus Therapeutics Holding AB lowest stock price was €0.07 and its highest was €0.19 in the past 12 months.
What is Modus Therapeutics Holding AB’s market cap?
Modus Therapeutics Holding AB’s market cap is €4.32M.
When is Modus Therapeutics Holding AB’s upcoming earnings report date?
Modus Therapeutics Holding AB’s upcoming earnings report date is May 20, 2025 which is in 17 days.
How were Modus Therapeutics Holding AB’s earnings last quarter?
Modus Therapeutics Holding AB released its earnings results on Feb 20, 2025. The company reported -€0.012 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.012.
Is Modus Therapeutics Holding AB overvalued?
According to Wall Street analysts Modus Therapeutics Holding AB’s price is currently Overvalued.
Does Modus Therapeutics Holding AB pay dividends?
Modus Therapeutics Holding AB does not currently pay dividends.
What is Modus Therapeutics Holding AB’s EPS estimate?
Modus Therapeutics Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Modus Therapeutics Holding AB have?
Modus Therapeutics Holding AB has 35,938,900 shares outstanding.
What happened to Modus Therapeutics Holding AB’s price movement after its last earnings report?
Modus Therapeutics Holding AB reported an EPS of -€0.012 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Modus Therapeutics Holding AB?
Currently, no hedge funds are holding shares in DE:99Z
---
Company Description
Modus Therapeutics Holding AB
Modus Therapeutics Holding AB is a clinical biotechnology company developing a treatment for sepsis and septic shock through the patented polysaccharide sevuparin. The drug candidate sevuparin has the opportunity to benefit patients and save large healthcare costs.
---
Technical Analysis
Stayble Therapeutics AB
―
ExpreS2ion Biotech Holding AB
―
Spago Nanomedical AB
―
CombiGene AB
―
Sprint Bioscience AB
―
---